Immunotherapy in multiple myeloma--possibility or probability?
about
Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple MyelomaTreatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cellsImmunotherapy using dendritic cells against multiple myeloma: how to improve?Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.NY-ESO-1 immunotherapy for multiple myeloma.Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.Immunodeficiency and immunotherapy in multiple myeloma.Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myelomaHumoral immunotherapy of multiple myeloma: perspectives and perplexities.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Monoclonal antibody-based immunotherapy for multiple myeloma.Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells.Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Poorex vivoinduction of T-cell responses to idiotype or tumor cell lysate-pulsed autologous dendritic cells in advanced pre-treated multiple myeloma
P2860
Q34292398-63A7B8D0-DC4D-4C49-BC3C-F0FCE3F31E1FQ34694749-D070090F-BBC2-4F6F-9926-6D04299664D1Q34985537-BD4B1E36-5982-4C36-B7F0-057B6A549823Q35852574-FB8F3306-4D7D-4E3A-9570-B41D21839C17Q36545286-92E6ACDC-0071-4433-B999-D07A220BCB5CQ36637651-EEDA22C9-7BC4-4886-8CA4-44F5FC2EC809Q36844954-1A92B8AF-AD79-4952-8BC6-C291913A323EQ36904977-6B40D344-2159-48EC-A7E5-42F83202820AQ37089674-5B2A3484-B9AB-4BBA-96FE-187954566EFEQ37724368-926DBF00-3D57-4C93-9C80-B81B422F6C19Q38014834-995A8027-3D82-47F4-BA60-FD7681EBED36Q38050507-39E47D3E-A1E6-475E-A11F-42503B422A5BQ38729516-4699759D-9AD5-4440-A87A-7C0C519B6006Q41233921-2F7E0DE2-271F-4D83-B96F-FBD70832F13DQ46965111-903FF6A3-8315-4312-8173-52799D12A19FQ57314084-1437FBE5-9703-42B3-911C-C5F8A69656C2
P2860
Immunotherapy in multiple myeloma--possibility or probability?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immunotherapy in multiple myeloma--possibility or probability?
@ast
Immunotherapy in multiple myeloma--possibility or probability?
@en
type
label
Immunotherapy in multiple myeloma--possibility or probability?
@ast
Immunotherapy in multiple myeloma--possibility or probability?
@en
prefLabel
Immunotherapy in multiple myeloma--possibility or probability?
@ast
Immunotherapy in multiple myeloma--possibility or probability?
@en
P2860
P1476
Immunotherapy in multiple myeloma--possibility or probability?
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.2005.05534.X
P407
P577
2005-08-01T00:00:00Z